NOVO.B.DK

239.4

-2.25%↓

GMAB.DK

1,828

-0.65%↓

HLUNB.DK

39.14

+0.05%↑

AMBUB.DK

78

-1.39%↓

NOVO.B.DK

239.4

-2.25%↓

GMAB.DK

1,828

-0.65%↓

HLUNB.DK

39.14

+0.05%↑

AMBUB.DK

78

-1.39%↓

NOVO.B.DK

239.4

-2.25%↓

GMAB.DK

1,828

-0.65%↓

HLUNB.DK

39.14

+0.05%↑

AMBUB.DK

78

-1.39%↓

NOVO.B.DK

239.4

-2.25%↓

GMAB.DK

1,828

-0.65%↓

HLUNB.DK

39.14

+0.05%↑

AMBUB.DK

78

-1.39%↓

NOVO.B.DK

239.4

-2.25%↓

GMAB.DK

1,828

-0.65%↓

HLUNB.DK

39.14

+0.05%↑

AMBUB.DK

78

-1.39%↓

Search

Coloplast A-S (Class B)

Avatud

480.4 -2.38

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

480.2

Max

494.8

Põhinäitajad

By Trading Economics

Sissetulek

522M

1.4B

Müük

83M

7B

P/E

Sektori keskmine

27.754

110.024

Aktsiakasum

6.32

Dividenditootlus

4.78

Kasumimarginaal

19.835

Töötajad

16,983

EBITDA

309M

2.3B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.86% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

4.78%

2.26%

Järgmine tulemuste avaldamine

12. mai 2026

Järgmine dividendimakse kuupäev

20. mai 2026

Järgmine aktsia dividendi kuupäev (ex-date)

18. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-7.8B

111B

Eelmine avamishind

482.78

Eelmine sulgemishind

480.4

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. veebr 2026, 23:07 UTC

Tulu

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24. veebr 2026, 23:01 UTC

Tulu

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24. veebr 2026, 22:59 UTC

Tulu

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24. veebr 2026, 22:42 UTC

Tulu

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24. veebr 2026, 22:24 UTC

Omandamised, ülevõtmised, äriostud

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24. veebr 2026, 23:46 UTC

Market Talk

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24. veebr 2026, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24. veebr 2026, 23:30 UTC

Market Talk

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24. veebr 2026, 23:20 UTC

Market Talk

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24. veebr 2026, 23:20 UTC

Market Talk

Global Equities Roundup: Market Talk

24. veebr 2026, 23:16 UTC

Tulu

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24. veebr 2026, 23:13 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24. veebr 2026, 23:12 UTC

Tulu

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24. veebr 2026, 23:10 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24. veebr 2026, 23:10 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24. veebr 2026, 23:08 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24. veebr 2026, 23:07 UTC

Tulu

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24. veebr 2026, 22:52 UTC

Tulu

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24. veebr 2026, 22:46 UTC

Tulu

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24. veebr 2026, 22:31 UTC

Omandamised, ülevõtmised, äriostud

Warner Receives New Bid From Paramount -- 3rd Update

24. veebr 2026, 22:29 UTC

Tulu

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24. veebr 2026, 22:28 UTC

Tulu

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24. veebr 2026, 22:27 UTC

Tulu

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24. veebr 2026, 22:27 UTC

Tulu

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24. veebr 2026, 22:25 UTC

Tulu

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24. veebr 2026, 22:24 UTC

Tulu

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24. veebr 2026, 22:23 UTC

Tulu

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24. veebr 2026, 22:22 UTC

Tulu

Woolworths Interim Dividend 45 Australian Cents/Share

24. veebr 2026, 22:22 UTC

Tulu

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24. veebr 2026, 22:21 UTC

Tulu

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Võrdlus sarnastega

Hinnamuutus

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK  11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat